No United States patent specifically detailing acarbose biosynthesis was issued in 2021. Acarbose, an alpha-glucosidase inhibitor used to manage type 2 diabetes, is a product of fermentation and chemical synthesis, rather than direct biosynthesis in the manner often associated with simpler organic molecules.
What is Acarbose's Patent History?
Acarbose's foundational patents have long since expired. The original patents for acarbose were granted in the late 1970s and early 1980s. For instance, U.S. Patent No. 4,361,575, related to acarbose and its analogs, was filed in 1981 and issued in 1982, with its term now expired [1]. While new patents related to manufacturing processes, formulations, or specific crystalline forms might have been filed or issued in more recent years, these do not pertain to the fundamental biosynthesis of the molecule itself.
When Does Acarbose's Market Exclusivity End?
Market exclusivity for acarbose has largely concluded due to the expiration of its primary patents. This has paved the way for generic versions of the drug to enter the market.
What are the Manufacturing Methods for Acarbose?
Acarbose is typically produced through a complex process involving fermentation using specific microorganisms, followed by chemical modifications. The initial production step often utilizes the bacterium Actinoplanes utahensis [2]. Subsequent chemical steps are then employed to achieve the final acarbose molecule. DrugPatentWatch.com provides data on the patent landscape of various drugs, including information on patent expiry and any active patents related to manufacturing processes [3].
Who Manufactures Acarbose Generics?
Following patent expirations, several pharmaceutical companies have manufactured and marketed generic versions of acarbose. These include manufacturers in India and other regions, making the drug widely accessible.
What are the Approved Uses of Acarbose?
Acarbose is prescribed to improve glycemic control in adults with type 2 diabetes mellitus. It works by slowing down the digestion of carbohydrates, thereby reducing the postprandial (after-meal) rise in blood glucose levels.